Maxwell Biosciences Awarded “Most Promising” 2022 Life Sciences Company in Texas Competition

Joshua McClure 2/28/22 Joshua McClure 2/28/22

Maxwell Biosciences Awarded “Most Promising” 2022 Life Sciences Company in Texas Competition

Read More

New Research Published in ACS Infectious Diseases Examines Impact of Self-Assembly of Antimicrobial Peptoids on ESKAPE Bacterial Pathogens

Caroline B 2/23/22 Caroline B 2/23/22

New Research Published in ACS Infectious Diseases Examines Impact of Self-Assembly of Antimicrobial Peptoids on ESKAPE Bacterial Pathogens

Read More

Guest User 5/18/21 Guest User 5/18/21

Maxwell Biosciences Announces the CLAROMER® Brand Biotech Therapeutics Platform as It Advances Toward Clinical Trials

Read More

David Evans Shaw Invests in Maxwell Biosciences to Advance the New Class of Antiviral Drugs

Guest User 4/7/21 Guest User 4/7/21

David Evans Shaw Invests in Maxwell Biosciences to Advance the New Class of Antiviral Drugs

Read More

New research published in Pharmaceuticals (MDPI) demonstrates that several peptoids exhibit potent in vitro antiviral activity against both HSV-1 and SARS-CoV-2

Guest User 4/5/21 Guest User 4/5/21

New research published in Pharmaceuticals (MDPI) demonstrates that several peptoids exhibit potent in vitro antiviral activity against both HSV-1 and SARS-CoV-2

Read More

MEDIA ADVISORY:Maxwell Biosciences to Present at the Upcoming 2021 Spring Private Company Showcase Hosted by Credit Suisse, Solebury Trout, and Cooley

Guest User 3/10/21 Guest User 3/10/21

MEDIA ADVISORY:Maxwell Biosciences to Present at the Upcoming 2021 Spring Private Company Showcase Hosted by Credit Suisse, Solebury Trout, and Cooley

Read More

Guest User 3/3/21 Guest User 3/3/21

Maxwell Biosciences Appoints Kent Kirshenbaum, Ph.D. as Chief Scientific Officer and Sheetal Vali, Ph.D. as Director of Drug Development

Read More

Joshua McClure 6/11/19 Joshua McClure 6/11/19

Maxwell Focus: Next Generation Anti-infectives

Read More